United States S 3847: COVID–19 Emergency Manufacturing Act of 2020

Status: Introduced in Senate (as of 2020-06-01)

State: United States · Session: 116 · Bill: S 3847

Subjects: Blood and blood diseases, Cardiovascular and respiratory health, Congressional oversight, Corporate finance and management, Department of Health and Human Services, Drug safety, medical device, and laboratory regulation, Emergency medical services and trauma care, Executive agency funding and structure, Federal officials, Genetics, Government ethics and transparency, public corruption, Government information and archives, Government studies and investigations, Health personnel, Health technology, devices, supplies, Immunology and vaccination, Indian social and development programs, Infectious and parasitic diseases, Inflation and prices, Licensing and registrations, Manufacturing, Marketing and advertising, Medical tests and diagnostic methods, Minority health, Prescription drugs, Public contracts and procurement, Public participation and lobbying, State and local government operations, Strategic materials and reserves, Worker safety and health

Sponsors: Elizabeth A. Warren

View United States S 3847 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.